Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 23, 2017
The effect of information on preferences for treatments of metastatic renal cell carcinoma.
Journal: Current medical research and opinion
Published: July 13, 2016
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
Journal: American journal of hematology
Published: July 06, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With Sunitinib.
Journal: Clinical genitourinary cancer
Published: April 24, 2016
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.
Journal: American journal of hematology
Published: February 24, 2016
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features.
Journal: Clinical genitourinary cancer
Published: December 29, 2015
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
Journal: American journal of hematology
Published: March 31, 2015
Response to Miller et al: resistant mutations in CML and Ph(+) ALL - role of ponatinib.
Journal: Biologics : targets & therapy
Published: March 04, 2015
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Journal: British journal of cancer
Published: January 21, 2015
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib.
Journal: Cancer
Published: August 28, 2014
Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma.
Journal: Cancer
Published: October 28, 2013
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma.
Journal: British journal of cancer
Published: September 05, 2013
Last Updated: 09/26/2026